Haleon (HLN) Revenue & Revenue Breakdown
Haleon Revenue Highlights
Latest Revenue (Y)
$11.30B
Latest Revenue (Q)
$2.92B
Main Segment (Y)
Respiratory Health
Main Geography (Y)
Rest of World
Haleon Revenue by Period
Haleon Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $11.30B | 4.09% |
2022-12-31 | $10.86B | 13.76% |
2021-12-31 | $9.54B | -3.51% |
2020-12-31 | $9.89B | 16.65% |
2019-12-31 | $8.48B | - |
Haleon Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $2.92B | 5.53% |
2023-12-31 | $2.77B | -1.14% |
2023-09-30 | $2.80B | 1.67% |
2023-06-30 | $2.75B | -7.84% |
2023-03-31 | $2.99B | -21.28% |
2022-12-31 | $3.79B | 31.15% |
2022-09-30 | $2.89B | 12.92% |
2022-06-30 | $2.56B | -2.51% |
2022-03-31 | $2.63B | 79.32% |
2021-12-31 | $1.47B | -41.16% |
2021-09-30 | $2.49B | - |
Haleon Revenue Breakdown
Haleon Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 22 |
---|---|
Respiratory Health | $1.58B |
Latest
Quarterly Revenue by Product
Product/Service | Jun 23 |
---|---|
Respiratory Health | $839.00M |
Latest
Haleon Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 22 |
---|---|
CHINA | $907.00M |
Rest of World | $5.91B |
UNITED STATES | $3.69B |
Latest
Haleon Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TAK | Takeda Pharmaceutical Company | $4.26T | $1.05T |
RDY | Dr. Reddy's Laboratories | $279.16B | - |
TEVA | Teva Pharmaceutical Industries | $15.85B | $4.33B |
VTRS | Viatris | $15.43B | $3.74B |
HLN | Haleon | $11.30B | $2.92B |
BHC | Bausch Health Companies | $8.76B | $2.51B |
ZTS | Zoetis | $8.54B | $2.39B |
ELAN | Elanco Animal Health | $4.42B | $1.18B |
CTLT | Catalent | $4.38B | $1.02B |
NBIX | Neurocrine Biosciences | $1.89B | $622.10M |
LNTH | Lantheus | $1.30B | $378.73M |
EBS | Emergent BioSolutions | $1.05B | $254.70M |
HCM | HUTCHMED (China) | $838.00M | $152.56M |
SIGA | SIGA | $139.92M | $10.01M |
ESPR | Esperion Therapeutics | $116.33M | $51.63M |